Gastric mucosal atrophy is the final stage of chronic gastritis, however, it is difficult to detect because the symptoms are often nonspecific and easily misdiagnosed.

Atrophy of the gastric mucosa, if not treated early, can lead to gastric cancer on atrophic plaques. Therefore, early diagnosis of gastric mucosal atrophy is very important, helping patients reduce poor quality of life and prevent gastric cancer.

According to a study published in Lancet Oncology, the combination of ramucirumab and pembrolizumab showed good tolerability in phase I trials for several malignancies such as gastric adenocarcinoma and gastric junction cancer. Esophageal.

Chronic gastritis in the final stage begins to appear atrophic gastritis of the gastric mucosa. Gastric mucosal cells are lost or replaced by intestinal mucosal epithelial cells, pyloric glands, and fibrous tissue. Atrophic gastritis caused by Helicobacter pylori often has no symptoms, but the risk of stomach cancer is very high.